Central Composite Designed Formulation, Characterization and In-Vitro Cytotoxic effect of Erlotinib Loaded Chitosan Nanoparticulate System

Parijat Pandey, Dinesh Kumar Chellappan, Murtaza M Tambuwala, Hamid Bakshi, Kamal Dua, Harish Dureja

Research output: Contribution to journalArticle

Abstract

The most common cause of deaths due to cancers nowadays is lung cancer. The objective of this study was to prepare erlotinib loaded chitosan nanoparticles for their anticancer potential. To study the effect of formulation variables on prepared nanoparticles using central composite design. Erlotinib loaded chitosan nanoparticles were prepared by ionic gelation method using probe sonication technique. It was found that batch NP-7 has a maximum loading capacity and entrapment efficiency with a particle size (138.5 nm) which is ideal for targeting solid tumors. Analysis of variance was applied to the particle size, entrapment efficiency and percent cumulative drug release to study the fitting and the significance of the model. The batch NP-7 showed 91.57% and 39.78% drug release after 24 h in 0.1 N hydrochloric acid and Phosphate Buffer (PB) pH 6.8, respectively. The IC 50 value of NP-7 evaluated on A549 Lung cancer cells was found to be 6.36 μM. The XRD of NP-7 displayed the existence of erlotinib in the amorphous pattern. The optimized batch released erlotinib slowly in comparison to the marketed tablet formulation. Erlotinib loaded chitosan nanoparticles were prepared successfully using sonication technique with suitable particle size, entrapment efficiency and drug release. The formulated nanoparticles can be utilized for the treatment of lung cancer.

LanguageEnglish
Pages596-610
Number of pages15
JournalInternational Journal of Biological Macromolecules
Volume141
Early online date5 Sep 2019
DOIs
Publication statusPublished - 1 Dec 2019

Fingerprint

Chitosan
Nanoparticles
Particle Size
Composite materials
Lung Neoplasms
Sonication
Particle size
Pharmaceutical Preparations
Hydrochloric Acid
Gelation
Hydrochloric acid
Analysis of variance (ANOVA)
Tablets
Tumors
Cause of Death
Neoplasms
Analysis of Variance
Buffers
Phosphates
Cells

Keywords

  • ErlotinibIonic gelationProbe sonication
  • Erlotinib
  • Ionic gelation
  • Probe sonication

Cite this

@article{be15fb290c884e059c138246f5b66395,
title = "Central Composite Designed Formulation, Characterization and In-Vitro Cytotoxic effect of Erlotinib Loaded Chitosan Nanoparticulate System",
abstract = "The most common cause of deaths due to cancers nowadays is lung cancer. The objective of this study was to prepare erlotinib loaded chitosan nanoparticles for their anticancer potential. To study the effect of formulation variables on prepared nanoparticles using central composite design. Erlotinib loaded chitosan nanoparticles were prepared by ionic gelation method using probe sonication technique. It was found that batch NP-7 has a maximum loading capacity and entrapment efficiency with a particle size (138.5 nm) which is ideal for targeting solid tumors. Analysis of variance was applied to the particle size, entrapment efficiency and percent cumulative drug release to study the fitting and the significance of the model. The batch NP-7 showed 91.57{\%} and 39.78{\%} drug release after 24 h in 0.1 N hydrochloric acid and Phosphate Buffer (PB) pH 6.8, respectively. The IC 50 value of NP-7 evaluated on A549 Lung cancer cells was found to be 6.36 μM. The XRD of NP-7 displayed the existence of erlotinib in the amorphous pattern. The optimized batch released erlotinib slowly in comparison to the marketed tablet formulation. Erlotinib loaded chitosan nanoparticles were prepared successfully using sonication technique with suitable particle size, entrapment efficiency and drug release. The formulated nanoparticles can be utilized for the treatment of lung cancer.",
keywords = "ErlotinibIonic gelationProbe sonication, Erlotinib, Ionic gelation, Probe sonication",
author = "Parijat Pandey and Chellappan, {Dinesh Kumar} and Tambuwala, {Murtaza M} and Hamid Bakshi and Kamal Dua and Harish Dureja",
year = "2019",
month = "12",
day = "1",
doi = "10.1016/j.ijbiomac.2019.09.023",
language = "English",
volume = "141",
pages = "596--610",
journal = "International Journal of Biological Macromolecules",
issn = "0141-8130",
publisher = "Elsevier",

}

Central Composite Designed Formulation, Characterization and In-Vitro Cytotoxic effect of Erlotinib Loaded Chitosan Nanoparticulate System. / Pandey, Parijat; Chellappan, Dinesh Kumar; Tambuwala, Murtaza M; Bakshi, Hamid ; Dua, Kamal; Dureja, Harish.

In: International Journal of Biological Macromolecules, Vol. 141, 01.12.2019, p. 596-610.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Central Composite Designed Formulation, Characterization and In-Vitro Cytotoxic effect of Erlotinib Loaded Chitosan Nanoparticulate System

AU - Pandey, Parijat

AU - Chellappan, Dinesh Kumar

AU - Tambuwala, Murtaza M

AU - Bakshi, Hamid

AU - Dua, Kamal

AU - Dureja, Harish

PY - 2019/12/1

Y1 - 2019/12/1

N2 - The most common cause of deaths due to cancers nowadays is lung cancer. The objective of this study was to prepare erlotinib loaded chitosan nanoparticles for their anticancer potential. To study the effect of formulation variables on prepared nanoparticles using central composite design. Erlotinib loaded chitosan nanoparticles were prepared by ionic gelation method using probe sonication technique. It was found that batch NP-7 has a maximum loading capacity and entrapment efficiency with a particle size (138.5 nm) which is ideal for targeting solid tumors. Analysis of variance was applied to the particle size, entrapment efficiency and percent cumulative drug release to study the fitting and the significance of the model. The batch NP-7 showed 91.57% and 39.78% drug release after 24 h in 0.1 N hydrochloric acid and Phosphate Buffer (PB) pH 6.8, respectively. The IC 50 value of NP-7 evaluated on A549 Lung cancer cells was found to be 6.36 μM. The XRD of NP-7 displayed the existence of erlotinib in the amorphous pattern. The optimized batch released erlotinib slowly in comparison to the marketed tablet formulation. Erlotinib loaded chitosan nanoparticles were prepared successfully using sonication technique with suitable particle size, entrapment efficiency and drug release. The formulated nanoparticles can be utilized for the treatment of lung cancer.

AB - The most common cause of deaths due to cancers nowadays is lung cancer. The objective of this study was to prepare erlotinib loaded chitosan nanoparticles for their anticancer potential. To study the effect of formulation variables on prepared nanoparticles using central composite design. Erlotinib loaded chitosan nanoparticles were prepared by ionic gelation method using probe sonication technique. It was found that batch NP-7 has a maximum loading capacity and entrapment efficiency with a particle size (138.5 nm) which is ideal for targeting solid tumors. Analysis of variance was applied to the particle size, entrapment efficiency and percent cumulative drug release to study the fitting and the significance of the model. The batch NP-7 showed 91.57% and 39.78% drug release after 24 h in 0.1 N hydrochloric acid and Phosphate Buffer (PB) pH 6.8, respectively. The IC 50 value of NP-7 evaluated on A549 Lung cancer cells was found to be 6.36 μM. The XRD of NP-7 displayed the existence of erlotinib in the amorphous pattern. The optimized batch released erlotinib slowly in comparison to the marketed tablet formulation. Erlotinib loaded chitosan nanoparticles were prepared successfully using sonication technique with suitable particle size, entrapment efficiency and drug release. The formulated nanoparticles can be utilized for the treatment of lung cancer.

KW - ErlotinibIonic gelationProbe sonication

KW - Erlotinib

KW - Ionic gelation

KW - Probe sonication

UR - http://www.scopus.com/inward/record.url?scp=85072021809&partnerID=8YFLogxK

U2 - 10.1016/j.ijbiomac.2019.09.023

DO - 10.1016/j.ijbiomac.2019.09.023

M3 - Article

VL - 141

SP - 596

EP - 610

JO - International Journal of Biological Macromolecules

T2 - International Journal of Biological Macromolecules

JF - International Journal of Biological Macromolecules

SN - 0141-8130

ER -